David Piacquad Amgen Inc (AMGN) insider trading activity

AMGN Quotes by TradingView

David Piacquad is SVP, Business Development of AMGEN INC. Currently has a direct ownership of 44,787 shares of AMGN, which is worth approximately $14.3 Million. The most recent transaction as insider was on Jan 30, 2015, when has been sold 1,050 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.8K
0% 3M change
0% 12M change
Total Value Held $14.3 Million

David Piacquad Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 30 2015
BUY
Grant, award, or other acquisition
-
1,050 Added 3.76%
26,862 Common Stock
Aug 03 2014
SELL
Payment of exercise price or tax liability
-
1,957 Reduced 7.07%
25,711 Common Stock
Apr 27 2014
SELL
Payment of exercise price or tax liability
$29,969 $111.41 p/Share
269 Reduced 0.97%
27,604 Common Stock
Apr 25 2014
SELL
Payment of exercise price or tax liability
$36,390 $113.72 p/Share
320 Reduced 1.18%
26,707 Common Stock
Apr 25 2014
BUY
Grant, award, or other acquisition
-
1,166 Added 4.02%
27,873 Common Stock

Also insider at

NMRA
Neumora Therapeutics, Inc.
DP

David Piacquad

SVP, Business Development
Thousand Oaks, CA

Track Institutional and Insider Activities on AMGN

Follow AMGEN INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMGN shares.

Notify only if

Insider Trading

Get notified when an Amgen Inc insider buys or sells AMGN shares.

Notify only if

News

Receive news related to AMGEN INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AMGN